• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    Jubilant Pharmova Limited — Updates, 02-12-2025: General Updates

    02-12-2025 | 08:45 am

    Jubilant Pharmova announced Daniel J. O’Connor as CEO of its proprietary drugs subsidiary, Jubilant Therapeutics Inc. O'Connor's 30+ years of biotech/oncology leadership, marked by value creation and successful acquisitions, is poised to drive innovation and growth for the unit.

    No comments yet. Be the first to comment!

    All announcements from Jubilant Pharmova Limited